Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Breast Neoplasm Malignant Female × gedatolisib × Clear all

Status

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Neoplasm Metastasis 3 Colorectal Neoplasms 2 Breast Neoplasms 2 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Prostatic Diseases 1 Male Urogenital Diseases 1 Hereditary Sensory and Autonomic Neuropathies 1 Genital Diseases, Male 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasm Malignant Female 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05134922 2025-03-21

Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009

Celcuity Inc

Breast Neoplasm Malignant Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡